The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced it has secured $65 million in ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...